Semaglutide is a GLP-1 receptor agonist that mimics the action of the GLP-1 hormone, which plays a crucial role in regulating blood sugar levels and appetite. By stimulating GLP-1 receptors, Semaglutide enhances insulin secretion, reduces glucagon production, slows gastric emptying, and promotes satiety. These combined effects make it highly effective for managing type 2 diabetes and assisting with weight loss. Semaglutide is available as a once-weekly injectable solution, which makes it convenient for long-term use.

Starting dose: 0.25 mg per week to minimize side effects like nausea.

Titration: increase to 0.5 mg per week after 4 weeks if well-tolerated.

Maximum dose: up to 2.4 mg per week, typically used for appetite control and fat loss.

Semaglutide 2 mg is administered via subcutaneous injection once a week. The injection can be given in the abdomen, thigh, or upper arm, and it is essential to rotate injection sites to avoid irritation and tissue damage. The dosage may be gradually increased based on the patient's response and tolerance, with a typical starting dose of 0.25 mg per week for the first four weeks, followed by an increase to 0.5 mg per week. The dose can be further adjusted by a healthcare provider as needed.

Patients should receive training on proper injection techniques and should always follow the instructions provided by their healthcare provider. It is also important to store Semaglutide in a refrigerator and protect it from light until it is ready to be used.

While Semaglutide is generally well-tolerated, some users may experience side effects:

Nausea and Vomiting: nausea is one of the most common side effects of Semaglutide, especially when starting treatment or increasing the dose. This side effect typically improves as the body adjusts to the medication.

Diarrhea: some users may experience diarrhea while taking Semaglutide. This side effect is usually temporary and can be managed with dietary adjustments and hydration.

Constipation: in contrast to diarrhea, some individuals may experience constipation. Drinking plenty of water and consuming high-fiber foods can help alleviate this issue.

Abdominal Pain: mild abdominal pain or discomfort can occur, particularly during the initial phase of treatment. This side effect is generally transient and resolves as the body adapts to the medication.

Hypoglycemia: although less common, hypoglycemia can occur, especially if Semaglutide is used in conjunction with other diabetes medications, such as sulfonylureas or insulin. Monitoring blood sugar levels and adjusting medications as needed can help prevent this side effect.

Pancreatitis: in rare cases, Semaglutide has been associated with pancreatitis (inflammation of the pancreas). Symptoms include severe abdominal pain, nausea, and vomiting. If these symptoms occur, it is crucial to seek medical attention immediately.

We prioritize quality and are committed to producing only the best products. Every steroid we manufacture undergoes rigorous laboratory testing to ensure safety, purity, and effectiveness. You can explore the full range of our tested and certified products right here. Your trust in our quality is our top priority.